These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8790153)

  • 1. Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit.
    Barstad RM; Ovrum E; Ringdal MA; Oystese R; Hamers MJ; Veiby OP; Rolfsen T; Stephens RW; Sakariassen KS
    Br J Haematol; 1996 Sep; 94(3):517-25. PubMed ID: 8790153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte procoagulant activity induced by adherence to an artificial surface is reduced by end-point immobilized heparin-coating of the surface.
    Barstad RM; Hamers MJ; Møller AS; Sakariassen KS
    Thromb Haemost; 1998 Feb; 79(2):302-5. PubMed ID: 9493580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface.
    Johnell M; Elgue G; Thelin S; Larsson R; Siegbahn A
    Scand Cardiovasc J; 2002 Dec; 36(6):351-7. PubMed ID: 12626202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of procoagulant phospholipids on the surface of platelets in patients undergoing cardiopulmonary bypass using non-coated and heparin-coated extracorporeal circuits.
    Weerwind PW; Caberg NE; Reutelingsperger CP; Lindhout T; de Jong DS
    Int J Artif Organs; 2002 Aug; 25(8):770-6. PubMed ID: 12296461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor is expressed on monocytes during simulated extracorporeal circulation.
    Kappelmayer J; Bernabei A; Edmunds LH; Edgington TS; Colman RW
    Circ Res; 1993 May; 72(5):1075-81. PubMed ID: 8097439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated extracorporeal circuits. A clinical pilot study.
    Bouma M; Maessen J; Weerwind P; Dentener M; Fransen E; de Jong D; Buurman W
    Chest; 1997 Mar; 111(3):577-83. PubMed ID: 9118690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
    J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
    Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit.
    Palatianos GM; Foroulis CN; Vassili MI; Astras G; Triantafillou K; Papadakis E; Lidoriki AA; Iliopoulou E; Melissari EN
    Ann Thorac Surg; 2003 Jul; 76(1):129-35. PubMed ID: 12842526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.